FDA.jpg
 

CureDuchenne was honored to host a webinar on February 20, 2013, in collaboration with PPMD and MDA, to discuss accelerated approval for drugs for rare diseases. Dr. Robert Temple, director of the Office of Medical Policy of FDA’s Center for Drug Evaluation and Research, presented detailed information on the different options available to speed the approval of drugs. Dr. Temple also answered questions posed by the participants.

 

Please click here for the recording of the webinar.

You'll be prompted to enter your name and email address to view the recording.

Powered By Convio